Previous studies showed that PLK4 inhibition causes synthetic lethality in cancer cells with genomic amplification or overexpression of the centrosomal ubiquitin ligase TRIM37 which is a negative regulator of PCM59–62. The gene discussed is TRIM37; the disease is cancer.